Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19)

40Citations
Citations of this article
112Readers
Mendeley users who have this article in their library.
Get full text

Abstract

While the number of studies related to severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) is constantly growing, it is essential to provide a framework of modeling viral infections. Therefore, this review aims to describe the background presented by earlier used models for viral studies and an approach to design an "ideal" tissue model for SARS-CoV-2 infection. Due to the previous successful achievements in antiviral research and tissue engineering, combining the emerging techniques such as bioprinting, microfluidics, and organoid formation are considered to be one of the best approaches to form in vitro tissue models. The fabrication of an integrated multi-tissue bioprinted platform tailored for SARS-CoV-2 infection can be a great breakthrough that can help defeat coronavirus disease in 2019.

Cite

CITATION STYLE

APA

Shpichka, A., Bikmulina, P., Peshkova, M., Kosheleva, N., Zurina, I., Zahmatkesh, E., … Timashev, P. (2020). Engineering a model to study viral infections: Bioprinting, microfluidics, and organoids to defeat coronavirus disease 2019 (COVID-19). International Journal of Bioprinting, 6(4), 1–20. https://doi.org/10.18063/IJB.V6I4.302

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free